AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat

byiShook Opinion
Oct 30, 2024 - 10:00

Share

AbbVie easily beat third-quarter expectations and raised its earnings outlook for the year. AbbVie stock rose Wednesday. The post AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat appeared first on Investor's Business Daily.

AbbVie easily beat third-quarter expectations and raised its earnings outlook for the year. AbbVie stock rose Wednesday.

The post AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat appeared first on Investor's Business Daily.